These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18512248)

  • 1. IL-23/IL-17 immunity as a hallmark of Crohn's disease.
    Hölttä V; Klemetti P; Sipponen T; Westerholm-Ormio M; Kociubinski G; Salo H; Räsänen L; Kolho KL; Färkkilä M; Savilahti E; Vaarala O
    Inflamm Bowel Dis; 2008 Sep; 14(9):1175-84. PubMed ID: 18512248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
    Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease.
    Rintamäki H; Sipponen T; Salo HM; Vaarala O; Kolho KL
    World J Gastroenterol; 2010 Dec; 16(46):5845-51. PubMed ID: 21155006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes.
    Tiittanen M; Westerholm-Ormio M; Verkasalo M; Savilahti E; Vaarala O
    Clin Exp Immunol; 2008 Jun; 152(3):498-507. PubMed ID: 18435801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
    J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of IL-17A
    Li J; Doty AL; Tang Y; Berrie D; Iqbal A; Tan SA; Clare-Salzler MJ; Wallet SM; Glover SC
    Clin Exp Immunol; 2017 Oct; 190(1):143-153. PubMed ID: 28586085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
    Bennet SM; Polster A; Törnblom H; Isaksson S; Capronnier S; Tessier A; Le Nevé B; Simrén M; Öhman L
    Am J Gastroenterol; 2016 Aug; 111(8):1165-76. PubMed ID: 27272011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of Foxp3 expression and CD4+CD25+ regulatory T cells on the pathogenesis of childhood asthma].
    Luo ZX; Liu EM; Deng B; Li X; Chen KH; Wang LJ; Huang Y; Fu Z
    Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):267-71. PubMed ID: 16780646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2 enhances in situ level of Foxp3+ regulatory cells and modulates inflammatory cytokines in Crohn's disease.
    Li G; Ren J; Wang G; Gu G; Hu D; Ren H; Hong Z; Wu X; Liu S; Li J
    Int Immunopharmacol; 2014 Feb; 18(2):244-8. PubMed ID: 24369313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
    Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
    Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.
    Veny M; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Aliment Pharmacol Ther; 2010 Mar; 31(5):561-72. PubMed ID: 19958311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
    Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
    Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American tegumentary leishmaniasis: mRNA expression for Th1 and Treg mediators are predominant in patients with recent active disease.
    Souza MA; Almeida TM; Castro MC; Oliveira-Mendes AP; Almeida AF; Oliveira BC; Rocha LF; Medeiros AC; Brito ME; Dessein AJ; Pereira VR
    Immunobiology; 2016 Feb; 221(2):253-9. PubMed ID: 26572279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
    Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis.
    Rani L; Minz RW; Sharma A; Anand S; Gupta D; Panda NK; Sakhuja VK
    Cytokine; 2015 Feb; 71(2):261-7. PubMed ID: 25461407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.